

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | sarcomere organization (GO:0045214) | 9.28713246 |
| 2 | * cardiac myofibril assembly (GO:0055003) | 8.53172514 |
| 3 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 7.99660487 |
| 4 | muscle filament sliding (GO:0030049) | 7.87544734 |
| 5 | actin-myosin filament sliding (GO:0033275) | 7.87544734 |
| 6 | * myofibril assembly (GO:0030239) | 7.53232477 |
| 7 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 7.14627593 |
| 8 | * cardiac muscle contraction (GO:0060048) | 6.84568279 |
| 9 | cardiac muscle cell development (GO:0055013) | 6.72868012 |
| 10 | tricarboxylic acid cycle (GO:0006099) | 6.59967541 |
| 11 | actin-mediated cell contraction (GO:0070252) | 6.54332207 |
| 12 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 6.36963552 |
| 13 | cardiac muscle tissue morphogenesis (GO:0055008) | 6.35235551 |
| 14 | cardiac cell development (GO:0055006) | 6.32293181 |
| 15 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 6.27273672 |
| 16 | regulation of relaxation of muscle (GO:1901077) | 6.25390473 |
| 17 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 6.24604356 |
| 18 | ventricular cardiac muscle tissue morphogenesis (GO:0055010) | 6.03959420 |
| 19 | regulation of actin filament-based movement (GO:1903115) | 6.03568675 |
| 20 | heart process (GO:0003015) | 5.83486376 |
| 21 | heart contraction (GO:0060047) | 5.83486376 |
| 22 | adult heart development (GO:0007512) | 5.81981683 |
| 23 | regulation of sarcomere organization (GO:0060297) | 5.79891483 |
| 24 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 5.78716400 |
| 25 | * actomyosin structure organization (GO:0031032) | 5.75186447 |
| 26 | muscle tissue morphogenesis (GO:0060415) | 5.72020968 |
| 27 | regulation of skeletal muscle contraction (GO:0014819) | 5.71385545 |
| 28 | ventricular cardiac muscle cell action potential (GO:0086005) | 5.67424838 |
| 29 | plasma membrane repair (GO:0001778) | 5.60964911 |
| 30 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 5.59155968 |
| 31 | heart trabecula formation (GO:0060347) | 5.39706935 |
| 32 | * striated muscle contraction (GO:0006941) | 5.35765301 |
| 33 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 5.31262550 |
| 34 | * cardiac muscle hypertrophy (GO:0003300) | 5.25922760 |
| 35 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 5.21690862 |
| 36 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 5.08380946 |
| 37 | response to muscle activity (GO:0014850) | 5.01522687 |
| 38 | regulation of striated muscle contraction (GO:0006942) | 5.00844272 |
| 39 | * striated muscle hypertrophy (GO:0014897) | 4.96660302 |
| 40 | carnitine shuttle (GO:0006853) | 4.94852400 |
| 41 | actin filament-based movement (GO:0030048) | 4.87576149 |
| 42 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 4.81609858 |
| 43 | regulation of cell communication by electrical coupling (GO:0010649) | 4.78847561 |
| 44 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 4.78516794 |
| 45 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 4.72523965 |
| 46 | ATP synthesis coupled proton transport (GO:0015986) | 4.72523965 |
| 47 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 4.71687233 |
| 48 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 4.59307486 |
| 49 | negative regulation of cardiac muscle cell apoptotic process (GO:0010667) | 4.54487934 |
| 50 | oxidative phosphorylation (GO:0006119) | 4.51925595 |
| 51 | cell communication involved in cardiac conduction (GO:0086065) | 4.49612662 |
| 52 | regulation of membrane repolarization (GO:0060306) | 4.45476904 |
| 53 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 4.42825222 |
| 54 | regulation of coenzyme metabolic process (GO:0051196) | 4.42432180 |
| 55 | regulation of cofactor metabolic process (GO:0051193) | 4.42432180 |
| 56 | * regulation of the force of heart contraction (GO:0002026) | 4.41983956 |
| 57 | respiratory electron transport chain (GO:0022904) | 4.40792910 |
| 58 | * muscle hypertrophy (GO:0014896) | 4.37671896 |
| 59 | fatty acid transmembrane transport (GO:1902001) | 4.37603397 |
| 60 | cardiac muscle adaptation (GO:0014887) | 4.36528030 |
| 61 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 4.36528030 |
| 62 | muscle hypertrophy in response to stress (GO:0003299) | 4.36528030 |
| 63 | electron transport chain (GO:0022900) | 4.28111966 |
| 64 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 4.25628328 |
| 65 | regulation of cardioblast differentiation (GO:0051890) | 4.25550161 |
| 66 | negative regulation of striated muscle cell apoptotic process (GO:0010664) | 4.21245194 |
| 67 | skeletal muscle adaptation (GO:0043501) | 4.11898423 |
| 68 | muscle fiber development (GO:0048747) | 4.10898955 |
| 69 | regulation of ATPase activity (GO:0043462) | 4.05677395 |
| 70 | regulation of ATP catabolic process (GO:1903289) | 4.05677395 |
| 71 | cardiac chamber formation (GO:0003207) | 4.04815244 |
| 72 | regulation of cardiac muscle contraction (GO:0055117) | 4.02380169 |
| 73 | ventricular cardiac muscle cell development (GO:0055015) | 4.00383271 |
| 74 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 3.98926603 |
| 75 | regulation of calcium ion transmembrane transport (GO:1903169) | 3.98926603 |
| 76 | regulation of cardiac muscle cell contraction (GO:0086004) | 3.98569164 |
| 77 | skeletal muscle fiber development (GO:0048741) | 3.97188527 |
| 78 | cardiac muscle cell action potential involved in contraction (GO:0086002) | 3.96661857 |
| 79 | regulation of heart rate (GO:0002027) | 3.96289767 |
| 80 | negative regulation of protein localization to cell surface (GO:2000009) | 3.93420582 |
| 81 | cardiac muscle cell action potential (GO:0086001) | 3.92906890 |
| 82 | cell communication by electrical coupling (GO:0010644) | 3.90731842 |
| 83 | 2-oxoglutarate metabolic process (GO:0006103) | 3.88853077 |
| 84 | cardiac ventricle formation (GO:0003211) | 3.87591988 |
| 85 | negative regulation of potassium ion transport (GO:0043267) | 3.82652227 |
| 86 | striated muscle cell development (GO:0055002) | 3.82022548 |
| 87 | NADH metabolic process (GO:0006734) | 3.78435441 |
| 88 | myotube cell development (GO:0014904) | 3.77554994 |
| 89 | relaxation of cardiac muscle (GO:0055119) | 3.73749596 |
| 90 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 3.67481826 |
| 91 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 3.67481826 |
| 92 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.66961103 |
| 93 | glycogen catabolic process (GO:0005980) | 3.64763528 |
| 94 | muscle adaptation (GO:0043500) | 3.64472992 |
| 95 | regulation of muscle system process (GO:0090257) | 3.63585897 |
| 96 | carnitine transmembrane transport (GO:1902603) | 3.63487962 |
| 97 | regulation of sulfur metabolic process (GO:0042762) | 3.62908458 |
| 98 | glycogen biosynthetic process (GO:0005978) | 3.58426317 |
| 99 | glucan biosynthetic process (GO:0009250) | 3.58426317 |
| 100 | relaxation of muscle (GO:0090075) | 3.57244677 |
| 101 | regulation of sequestering of triglyceride (GO:0010889) | 3.56592018 |
| 102 | muscle cell cellular homeostasis (GO:0046716) | 3.55035980 |
| 103 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 3.54599647 |
| 104 | * regulation of heart contraction (GO:0008016) | 3.54065578 |
| 105 | creatine metabolic process (GO:0006600) | 3.51434772 |
| 106 | cardiac conduction (GO:0061337) | 3.48934471 |
| 107 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.46530194 |
| 108 | trabecula formation (GO:0060343) | 3.45699716 |
| 109 | * muscle contraction (GO:0006936) | 3.45682473 |
| 110 | positive regulation of cation channel activity (GO:2001259) | 3.44944907 |
| 111 | glucan catabolic process (GO:0009251) | 3.41629417 |
| 112 | regulation of muscle contraction (GO:0006937) | 3.40584754 |
| 113 | striated muscle adaptation (GO:0014888) | 3.40291517 |
| 114 | response to inactivity (GO:0014854) | 3.38909921 |
| 115 | regulation of heart rate by cardiac conduction (GO:0086091) | 3.37844984 |
| 116 | muscle cell fate commitment (GO:0042693) | 3.35139010 |
| 117 | regulation of myoblast differentiation (GO:0045661) | 3.33409901 |
| 118 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 3.32125607 |
| 119 | amino-acid betaine transport (GO:0015838) | 3.31537989 |
| 120 | carnitine transport (GO:0015879) | 3.31537989 |
| 121 | skeletal muscle contraction (GO:0003009) | 3.31368571 |
| 122 | positive regulation of heart rate (GO:0010460) | 3.30984607 |
| 123 | regulation of striated muscle cell apoptotic process (GO:0010662) | 3.30420936 |
| 124 | response to caffeine (GO:0031000) | 3.30234581 |
| 125 | * skeletal muscle tissue development (GO:0007519) | 3.28351659 |
| 126 | muscle cell development (GO:0055001) | 3.27200171 |
| 127 | * muscle system process (GO:0003012) | 3.26941353 |
| 128 | cellular polysaccharide catabolic process (GO:0044247) | 3.21956560 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 7.73856564 |
| 2 | * EP300_21415370_ChIP-Seq_HL-1_Mouse | 5.29212195 |
| 3 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 5.01590704 |
| 4 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 4.26289016 |
| 5 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 4.26289016 |
| 6 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 4.23242541 |
| 7 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 4.22622488 |
| 8 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.60209100 |
| 9 | * MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 3.37716046 |
| 10 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 3.27007141 |
| 11 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 3.18857116 |
| 12 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.98492648 |
| 13 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 2.82255408 |
| 14 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.76724218 |
| 15 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.70993819 |
| 16 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.68159290 |
| 17 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.40260560 |
| 18 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.09840217 |
| 19 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 2.09692650 |
| 20 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 2.02616804 |
| 21 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.02559968 |
| 22 | GATA1_22025678_ChIP-Seq_K562_Human | 2.00383912 |
| 23 | * NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.96538977 |
| 24 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.91312873 |
| 25 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.90951472 |
| 26 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.90846112 |
| 27 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.90368804 |
| 28 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.83587079 |
| 29 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.76162808 |
| 30 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.76133263 |
| 31 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.75665588 |
| 32 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.58321331 |
| 33 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.58262512 |
| 34 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.56721881 |
| 35 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.50549764 |
| 36 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.47403338 |
| 37 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.43361250 |
| 38 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.27088343 |
| 39 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.25227822 |
| 40 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.24367995 |
| 41 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.22126231 |
| 42 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.20151447 |
| 43 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.17595516 |
| 44 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.16954497 |
| 45 | VDR_22108803_ChIP-Seq_LS180_Human | 1.13747830 |
| 46 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.11883576 |
| 47 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.11726316 |
| 48 | GATA1_19941826_ChIP-Seq_K562_Human | 1.10113599 |
| 49 | * PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.09533547 |
| 50 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.09500131 |
| 51 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.07964317 |
| 52 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.07304849 |
| 53 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.05721026 |
| 54 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.03949482 |
| 55 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.03260626 |
| 56 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.03090202 |
| 57 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 1.02986222 |
| 58 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.02972304 |
| 59 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.02893420 |
| 60 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.00972234 |
| 61 | * TP63_22573176_ChIP-Seq_HFKS_Human | 1.00478880 |
| 62 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.98030178 |
| 63 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.97339936 |
| 64 | ATF3_27146783_Chip-Seq_COLON_Human | 0.96596807 |
| 65 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 0.96549041 |
| 66 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.96246574 |
| 67 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.95524175 |
| 68 | EZH2_22144423_ChIP-Seq_EOC_Human | 0.95102313 |
| 69 | GBX2_23144817_ChIP-Seq_PC3_Human | 0.94272793 |
| 70 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.94045864 |
| 71 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.93073963 |
| 72 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.92568761 |
| 73 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.91708837 |
| 74 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.90445916 |
| 75 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.90442547 |
| 76 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 0.90023974 |
| 77 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 0.90023974 |
| 78 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.89491545 |
| 79 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.89491545 |
| 80 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.88614660 |
| 81 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.88407421 |
| 82 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.88391790 |
| 83 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.87912064 |
| 84 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.87839726 |
| 85 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.87720613 |
| 86 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.87633194 |
| 87 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.87480952 |
| 88 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.87446098 |
| 89 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.87342485 |
| 90 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.86728002 |
| 91 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.86431833 |
| 92 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.86258664 |
| 93 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.86189931 |
| 94 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.85390607 |
| 95 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.85295073 |
| 96 | GATA2_19941826_ChIP-Seq_K562_Human | 0.83589811 |
| 97 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.83261009 |
| 98 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.83167105 |
| 99 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 0.83053908 |
| 100 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.82096124 |
| 101 | GF1_26923725_Chip-Seq_HPCs_Mouse | 0.81777611 |
| 102 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.81705327 |
| 103 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.81505382 |
| 104 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.81127073 |
| 105 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.80891842 |
| 106 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.79551994 |
| 107 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.79226739 |
| 108 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.78429409 |
| 109 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.78192674 |
| 110 | PRDM14_21183938_ChIP-Seq_MESCs_Mouse | 0.78013551 |
| 111 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.78008718 |
| 112 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.77965674 |
| 113 | CJUN_26792858_Chip-Seq_BT549_Human | 0.77727029 |
| 114 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.77481101 |
| 115 | P68_20966046_ChIP-Seq_HELA_Human | 0.77410828 |
| 116 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.76708542 |
| 117 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.76706596 |
| 118 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.75815245 |
| 119 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.75010095 |
| 120 | * PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.74965892 |
| 121 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.74931995 |
| 122 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.74421966 |
| 123 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.73849556 |
| 124 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.73537972 |
| 125 | TBL1_22424771_ChIP-Seq_293T_Human | 0.72124201 |
| 126 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.72080194 |
| 127 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.72032440 |
| 128 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.71514128 |
| 129 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.71358507 |
| 130 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.70867274 |
| 131 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.70549158 |
| 132 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 0.70508784 |
| 133 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.70273295 |
| 134 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.69852686 |
| 135 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.69357855 |
| 136 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.68315649 |
| 137 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.68027612 |
| 138 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.67527847 |
| 139 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.67524022 |
| 140 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.67344602 |
| 141 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.67007263 |
| 142 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.66050218 |
| 143 | * TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.65969576 |
| 144 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.65612539 |
| 145 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.65593126 |
| 146 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 0.65202270 |
| 147 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.65120784 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002837_dystrophic_cardiac_calcinosis | 6.58341909 |
| 2 | MP0004084_abnormal_cardiac_muscle | 6.17574352 |
| 3 | MP0003646_muscle_fatigue | 5.29472639 |
| 4 | MP0000751_myopathy | 4.90132870 |
| 5 | MP0004215_abnormal_myocardial_fiber | 4.74963901 |
| 6 | MP0004036_abnormal_muscle_relaxation | 4.47150172 |
| 7 | MP0000749_muscle_degeneration | 4.23146431 |
| 8 | * MP0005330_cardiomyopathy | 3.89413612 |
| 9 | * MP0002972_abnormal_cardiac_muscle | 3.26194788 |
| 10 | MP0008775_abnormal_heart_ventricle | 3.14871601 |
| 11 | * MP0004087_abnormal_muscle_fiber | 3.10312638 |
| 12 | MP0003137_abnormal_impulse_conducting | 2.92163123 |
| 13 | MP0001544_abnormal_cardiovascular_syste | 2.74477743 |
| 14 | MP0005385_cardiovascular_system_phenoty | 2.74477743 |
| 15 | * MP0010630_abnormal_cardiac_muscle | 2.69585714 |
| 16 | * MP0005620_abnormal_muscle_contractility | 2.69550655 |
| 17 | MP0000750_abnormal_muscle_regeneration | 2.56014263 |
| 18 | MP0006138_congestive_heart_failure | 2.55186559 |
| 19 | MP0002106_abnormal_muscle_physiology | 2.51318230 |
| 20 | MP0004484_altered_response_of | 2.48480681 |
| 21 | MP0003828_pulmonary_edema | 2.34763718 |
| 22 | MP0004130_abnormal_muscle_cell | 2.34588693 |
| 23 | MP0002269_muscular_atrophy | 2.31814576 |
| 24 | MP0003221_abnormal_cardiomyocyte_apopto | 2.27552491 |
| 25 | MP0004145_abnormal_muscle_electrophysio | 2.23855196 |
| 26 | MP0004510_myositis | 2.09870805 |
| 27 | * MP0004085_abnormal_heartbeat | 2.09441499 |
| 28 | MP0005369_muscle_phenotype | 2.01985202 |
| 29 | MP0000747_muscle_weakness | 1.97602704 |
| 30 | MP0006036_abnormal_mitochondrial_physio | 1.90448005 |
| 31 | MP0000759_abnormal_skeletal_muscle | 1.89815948 |
| 32 | MP0002127_abnormal_cardiovascular_syste | 1.87612087 |
| 33 | MP0003950_abnormal_plasma_membrane | 1.74731294 |
| 34 | MP0004233_abnormal_muscle_weight | 1.59751252 |
| 35 | MP0003567_abnormal_fetal_cardiomyocyte | 1.49950406 |
| 36 | MP0002332_abnormal_exercise_endurance | 1.40123283 |
| 37 | MP0005666_abnormal_adipose_tissue | 1.23876294 |
| 38 | MP0010368_abnormal_lymphatic_system | 1.20278041 |
| 39 | * MP0000266_abnormal_heart_morphology | 1.18043451 |
| 40 | MP0000343_altered_response_to | 1.16982684 |
| 41 | MP0003806_abnormal_nucleotide_metabolis | 1.12449488 |
| 42 | MP0005451_abnormal_body_composition | 1.12274715 |
| 43 | MP0006035_abnormal_mitochondrial_morpho | 1.10367693 |
| 44 | MP0005670_abnormal_white_adipose | 1.07974423 |
| 45 | MP0003279_aneurysm | 1.06717450 |
| 46 | MP0005165_increased_susceptibility_to | 1.04245695 |
| 47 | MP0002234_abnormal_pharynx_morphology | 1.03736888 |
| 48 | MP0001661_extended_life_span | 0.93505251 |
| 49 | MP0005266_abnormal_metabolism | 0.87030631 |
| 50 | MP0000230_abnormal_systemic_arterial | 0.85835117 |
| 51 | MP0002128_abnormal_blood_circulation | 0.84351425 |
| 52 | MP0003566_abnormal_cell_adhesion | 0.82978109 |
| 53 | MP0005375_adipose_tissue_phenotype | 0.79754639 |
| 54 | MP0004185_abnormal_adipocyte_glucose | 0.78092960 |
| 55 | MP0004270_analgesia | 0.77664533 |
| 56 | MP0002108_abnormal_muscle_morphology | 0.75213773 |
| 57 | MP0003705_abnormal_hypodermis_morpholog | 0.71911538 |
| 58 | MP0000767_abnormal_smooth_muscle | 0.64941431 |
| 59 | MP0001879_abnormal_lymphatic_vessel | 0.62724571 |
| 60 | MP0004272_abnormal_basement_membrane | 0.60557930 |
| 61 | MP0005319_abnormal_enzyme/_coenzyme | 0.59111095 |
| 62 | MP0002822_catalepsy | 0.58930917 |
| 63 | MP0005085_abnormal_gallbladder_physiolo | 0.58906156 |
| 64 | MP0003045_fibrosis | 0.58830750 |
| 65 | MP0000733_abnormal_muscle_development | 0.55879439 |
| 66 | MP0002909_abnormal_adrenal_gland | 0.54996292 |
| 67 | MP0009780_abnormal_chondrocyte_physiolo | 0.52052869 |
| 68 | MP0005623_abnormal_meninges_morphology | 0.51608913 |
| 69 | MP0004043_abnormal_pH_regulation | 0.50857501 |
| 70 | MP0000013_abnormal_adipose_tissue | 0.49970009 |
| 71 | MP0003984_embryonic_growth_retardation | 0.49835297 |
| 72 | MP0002971_abnormal_brown_adipose | 0.49653656 |
| 73 | MP0002925_abnormal_cardiovascular_devel | 0.49558758 |
| 74 | MP0002088_abnormal_embryonic_growth/wei | 0.49360897 |
| 75 | MP0009384_cardiac_valve_regurgitation | 0.48888678 |
| 76 | MP0001299_abnormal_eye_distance/ | 0.48239816 |
| 77 | MP0005275_abnormal_skin_tensile | 0.46391712 |
| 78 | MP0004147_increased_porphyrin_level | 0.46311767 |
| 79 | MP0000003_abnormal_adipose_tissue | 0.43545569 |
| 80 | MP0008569_lethality_at_weaning | 0.42876910 |
| 81 | MP0002078_abnormal_glucose_homeostasis | 0.42205088 |
| 82 | MP0005187_abnormal_penis_morphology | 0.40578651 |
| 83 | MP0001784_abnormal_fluid_regulation | 0.40258761 |
| 84 | MP0008438_abnormal_cutaneous_collagen | 0.40214133 |
| 85 | MP0001614_abnormal_blood_vessel | 0.40028977 |
| 86 | MP0000372_irregular_coat_pigmentation | 0.37167532 |
| 87 | MP0005332_abnormal_amino_acid | 0.35858575 |
| 88 | MP0009840_abnormal_foam_cell | 0.35456189 |
| 89 | MP0005083_abnormal_biliary_tract | 0.33000443 |
| 90 | MP0002638_abnormal_pupillary_reflex | 0.32515124 |
| 91 | MP0003195_calcinosis | 0.32112223 |
| 92 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.32093824 |
| 93 | MP0003948_abnormal_gas_homeostasis | 0.30015383 |
| 94 | MP0005595_abnormal_vascular_smooth | 0.29990630 |
| 95 | MP0000762_abnormal_tongue_morphology | 0.29963686 |
| 96 | MP0002118_abnormal_lipid_homeostasis | 0.29848644 |
| 97 | MP0005535_abnormal_body_temperature | 0.29697515 |
| 98 | MP0001672_abnormal_embryogenesis/_devel | 0.26731635 |
| 99 | MP0005380_embryogenesis_phenotype | 0.26731635 |
| 100 | MP0008961_abnormal_basal_metabolism | 0.26558877 |
| 101 | MP0004134_abnormal_chest_morphology | 0.24980943 |
| 102 | MP0005376_homeostasis/metabolism_phenot | 0.24435510 |
| 103 | MP0001727_abnormal_embryo_implantation | 0.24198871 |
| 104 | MP0000249_abnormal_blood_vessel | 0.22711505 |
| 105 | MP0005167_abnormal_blood-brain_barrier | 0.22157516 |
| 106 | MP0003656_abnormal_erythrocyte_physiolo | 0.22056566 |
| 107 | MP0003941_abnormal_skin_development | 0.21230589 |
| 108 | MP0005503_abnormal_tendon_morphology | 0.20755084 |
| 109 | MP0005334_abnormal_fat_pad | 0.20087000 |
| 110 | MP0002133_abnormal_respiratory_system | 0.20086776 |
| 111 | MP0005388_respiratory_system_phenotype | 0.20086776 |
| 112 | MP0003879_abnormal_hair_cell | 0.18580935 |
| 113 | MP0009250_abnormal_appendicular_skeleto | 0.17779321 |
| 114 | MP0005452_abnormal_adipose_tissue | 0.16944602 |
| 115 | MP0008874_decreased_physiological_sensi | 0.16312711 |
| 116 | MP0010030_abnormal_orbit_morphology | 0.16244450 |
| 117 | MP0002114_abnormal_axial_skeleton | 0.15989121 |
| 118 | MP0005166_decreased_susceptibility_to | 0.15664985 |
| 119 | MP0009672_abnormal_birth_weight | 0.15371699 |
| 120 | MP0000579_abnormal_nail_morphology | 0.15347092 |
| 121 | MP0005386_behavior/neurological_phenoty | 0.15224427 |
| 122 | MP0004924_abnormal_behavior | 0.15224427 |
| 123 | MP0001984_abnormal_olfaction | 0.14909236 |
| 124 | MP0002896_abnormal_bone_mineralization | 0.14798925 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Sudden death (HP:0001699) | 8.12935033 |
| 2 | Calf muscle hypertrophy (HP:0008981) | 6.40118108 |
| 3 | * Ventricular tachycardia (HP:0004756) | 6.38725052 |
| 4 | Exercise-induced muscle cramps (HP:0003710) | 6.08082642 |
| 5 | * Atrial fibrillation (HP:0005110) | 5.84314247 |
| 6 | Exercise-induced myalgia (HP:0003738) | 5.83434548 |
| 7 | Muscle hypertrophy of the lower extremities (HP:0008968) | 5.79673823 |
| 8 | * Primary atrial arrhythmia (HP:0001692) | 5.43701812 |
| 9 | * Lipoatrophy (HP:0100578) | 5.34079570 |
| 10 | Abnormality of the calf musculature (HP:0001430) | 5.29865277 |
| 11 | * Supraventricular tachycardia (HP:0004755) | 5.26520622 |
| 12 | Muscle fiber splitting (HP:0003555) | 5.24747829 |
| 13 | Subaortic stenosis (HP:0001682) | 5.23227875 |
| 14 | Abnormality of the left ventricular outflow tract (HP:0011103) | 5.23227875 |
| 15 | * Supraventricular arrhythmia (HP:0005115) | 5.15383699 |
| 16 | Right ventricular cardiomyopathy (HP:0011663) | 5.14923379 |
| 17 | Hyporeflexia of lower limbs (HP:0002600) | 5.05390954 |
| 18 | Myoglobinuria (HP:0002913) | 4.90953300 |
| 19 | Distal arthrogryposis (HP:0005684) | 4.89580472 |
| 20 | Syncope (HP:0001279) | 4.77815155 |
| 21 | Palpitations (HP:0001962) | 4.48428643 |
| 22 | * Dilated cardiomyopathy (HP:0001644) | 4.41098763 |
| 23 | Bundle branch block (HP:0011710) | 4.38229372 |
| 24 | Myopathic facies (HP:0002058) | 4.37855176 |
| 25 | Prolonged QT interval (HP:0001657) | 4.24540860 |
| 26 | EMG: myopathic abnormalities (HP:0003458) | 4.23233920 |
| 27 | Ventricular arrhythmia (HP:0004308) | 4.18781949 |
| 28 | Asymmetric septal hypertrophy (HP:0001670) | 4.07954155 |
| 29 | Round ear (HP:0100830) | 4.06148687 |
| 30 | Rhabdomyolysis (HP:0003201) | 3.86436142 |
| 31 | Heart block (HP:0012722) | 3.73629801 |
| 32 | Ulnar deviation of the wrist (HP:0003049) | 3.72987664 |
| 33 | Atrioventricular block (HP:0001678) | 3.58448015 |
| 34 | Increased connective tissue (HP:0009025) | 3.57682076 |
| 35 | Ventricular fibrillation (HP:0001663) | 3.54309280 |
| 36 | Abnormal atrioventricular conduction (HP:0005150) | 3.51825991 |
| 37 | Hepatic necrosis (HP:0002605) | 3.33437204 |
| 38 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.29634438 |
| 39 | Acute necrotizing encephalopathy (HP:0006965) | 3.28553817 |
| 40 | Calcaneovalgus deformity (HP:0001848) | 3.20040091 |
| 41 | Myotonia (HP:0002486) | 3.08657982 |
| 42 | Abnormal EKG (HP:0003115) | 3.05704120 |
| 43 | Frequent falls (HP:0002359) | 3.05308546 |
| 44 | Difficulty running (HP:0009046) | 3.01083526 |
| 45 | Left ventricular hypertrophy (HP:0001712) | 2.99876458 |
| 46 | Absent phalangeal crease (HP:0006109) | 2.93849634 |
| 47 | Hypoglycemic coma (HP:0001325) | 2.91931774 |
| 48 | Hepatocellular necrosis (HP:0001404) | 2.88578564 |
| 49 | Distal lower limb muscle weakness (HP:0009053) | 2.85163805 |
| 50 | Acute encephalopathy (HP:0006846) | 2.84926703 |
| 51 | Type 1 muscle fiber predominance (HP:0003803) | 2.83939663 |
| 52 | Ragged-red muscle fibers (HP:0003200) | 2.83064188 |
| 53 | Deformed tarsal bones (HP:0008119) | 2.81680319 |
| 54 | Ketoacidosis (HP:0001993) | 2.77472566 |
| 55 | Distal lower limb amyotrophy (HP:0008944) | 2.75969361 |
| 56 | Mitochondrial inheritance (HP:0001427) | 2.73186705 |
| 57 | * Palmoplantar keratoderma (HP:0000982) | 2.72456375 |
| 58 | Progressive macrocephaly (HP:0004481) | 2.71643873 |
| 59 | Conjunctival hamartoma (HP:0100780) | 2.71408974 |
| 60 | Cerebral edema (HP:0002181) | 2.65713315 |
| 61 | Increased CSF lactate (HP:0002490) | 2.62851374 |
| 62 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.58363448 |
| 63 | Neck muscle weakness (HP:0000467) | 2.57156627 |
| 64 | Muscle fiber inclusion bodies (HP:0100299) | 2.56917628 |
| 65 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.56076485 |
| 66 | Areflexia of lower limbs (HP:0002522) | 2.54206548 |
| 67 | Dicarboxylic aciduria (HP:0003215) | 2.53478257 |
| 68 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.53478257 |
| 69 | Difficulty climbing stairs (HP:0003551) | 2.50483078 |
| 70 | Increased muscle lipid content (HP:0009058) | 2.50437148 |
| 71 | Bulbar palsy (HP:0001283) | 2.43420561 |
| 72 | Scapular winging (HP:0003691) | 2.43331012 |
| 73 | Exercise intolerance (HP:0003546) | 2.41654888 |
| 74 | Abnormal finger flexion creases (HP:0006143) | 2.40449891 |
| 75 | Malignant hyperthermia (HP:0002047) | 2.40368751 |
| 76 | Muscle stiffness (HP:0003552) | 2.39961524 |
| 77 | Gowers sign (HP:0003391) | 2.35675402 |
| 78 | Lactic acidosis (HP:0003128) | 2.29108726 |
| 79 | Progressive muscle weakness (HP:0003323) | 2.28239011 |
| 80 | Rimmed vacuoles (HP:0003805) | 2.26039535 |
| 81 | Increased intramyocellular lipid droplets (HP:0012240) | 2.24649655 |
| 82 | Weak cry (HP:0001612) | 2.23762981 |
| 83 | Increased variability in muscle fiber diameter (HP:0003557) | 2.22999111 |
| 84 | Hip contracture (HP:0003273) | 2.22457709 |
| 85 | Pheochromocytoma (HP:0002666) | 2.21547713 |
| 86 | Limb-girdle muscle atrophy (HP:0003797) | 2.21212462 |
| 87 | Increased serum pyruvate (HP:0003542) | 2.20978502 |
| 88 | Abnormality of glycolysis (HP:0004366) | 2.20978502 |
| 89 | Respiratory failure (HP:0002878) | 2.20841842 |
| 90 | Abnormality of the foot musculature (HP:0001436) | 2.15051919 |
| 91 | Ketosis (HP:0001946) | 2.14339468 |
| 92 | Neoplasm of the adrenal gland (HP:0100631) | 2.13834496 |
| 93 | EMG: neuropathic changes (HP:0003445) | 2.11068965 |
| 94 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.10972552 |
| 95 | Lower limb amyotrophy (HP:0007210) | 2.07838538 |
| 96 | Double outlet right ventricle (HP:0001719) | 2.07317522 |
| 97 | Congenital malformation of the right heart (HP:0011723) | 2.07317522 |
| 98 | Generalized muscle weakness (HP:0003324) | 2.05941880 |
| 99 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.04558299 |
| 100 | Fetal akinesia sequence (HP:0001989) | 2.03800131 |
| 101 | Nemaline bodies (HP:0003798) | 2.03274464 |
| 102 | Hamartoma of the eye (HP:0010568) | 2.02150579 |
| 103 | Testicular atrophy (HP:0000029) | 2.01756698 |
| 104 | Abnormality of the shoulder girdle musculature (HP:0001435) | 2.01588626 |
| 105 | Neuroendocrine neoplasm (HP:0100634) | 2.00578463 |
| 106 | Proximal amyotrophy (HP:0007126) | 2.00279446 |
| 107 | Abnormality of alanine metabolism (HP:0010916) | 1.99296504 |
| 108 | Hyperalaninemia (HP:0003348) | 1.99296504 |
| 109 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.99296504 |
| 110 | Generalized aminoaciduria (HP:0002909) | 1.97140508 |
| 111 | Foot dorsiflexor weakness (HP:0009027) | 1.95861677 |
| 112 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.95294195 |
| 113 | Fatigable weakness (HP:0003473) | 1.94688716 |
| 114 | Abnormality of the neuromuscular junction (HP:0003398) | 1.94688716 |
| 115 | Waddling gait (HP:0002515) | 1.94648578 |
| 116 | Neoplasm of head and neck (HP:0012288) | 1.92367838 |
| 117 | Esophageal neoplasm (HP:0100751) | 1.92367838 |
| 118 | * Congestive heart failure (HP:0001635) | 1.92162153 |
| 119 | Spinal rigidity (HP:0003306) | 1.90458006 |
| 120 | Slender build (HP:0001533) | 1.89672278 |
| 121 | * Sudden cardiac death (HP:0001645) | 1.88516283 |
| 122 | Lipid accumulation in hepatocytes (HP:0006561) | 1.86627179 |
| 123 | Steppage gait (HP:0003376) | 1.84328026 |
| 124 | Hypoplastic left heart (HP:0004383) | 1.82473892 |
| 125 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 1.82375718 |
| 126 | Hyperammonemia (HP:0001987) | 1.81617322 |
| 127 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.81370536 |
| 128 | Muscular dystrophy (HP:0003560) | 1.81253843 |
| 129 | Abnormality of the calcaneus (HP:0008364) | 1.78672017 |
| 130 | Hypoplastic heart (HP:0001961) | 1.68531922 |
| 131 | Hyperkalemia (HP:0002153) | 1.67731955 |
| 132 | Limb-girdle muscle weakness (HP:0003325) | 1.57454680 |
| 133 | Limited hip movement (HP:0008800) | 1.51829797 |
| 134 | Facial diplegia (HP:0001349) | 1.50474312 |
| 135 | Abnormality of the musculature of the pelvis (HP:0001469) | 1.45264316 |
| 136 | Abnormality of the hip-girdle musculature (HP:0001445) | 1.45264316 |
| 137 | Aplasia of the musculature (HP:0100854) | 1.43133266 |
| 138 | Type 2 muscle fiber atrophy (HP:0003554) | 1.41574561 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | OBSCN | 5.96912902 |
| 2 | TTN | 5.37507605 |
| 3 | MYLK | 4.40015839 |
| 4 | PHKG2 | 3.52935018 |
| 5 | PHKG1 | 3.52935018 |
| 6 | LMTK2 | 3.46127732 |
| 7 | PKN2 | 3.36918047 |
| 8 | PDK3 | 3.23085692 |
| 9 | PDK4 | 3.23085692 |
| 10 | DMPK | 2.92502638 |
| 11 | STK24 | 2.64409708 |
| 12 | BCKDK | 2.62313803 |
| 13 | PIK3CA | 2.52270386 |
| 14 | TRIB3 | 2.46398265 |
| 15 | MUSK | 2.35952606 |
| 16 | NEK1 | 2.22606407 |
| 17 | TIE1 | 2.14008743 |
| 18 | PDK2 | 1.87467366 |
| 19 | PINK1 | 1.74337711 |
| 20 | ZAK | 1.61157164 |
| 21 | STK38L | 1.45796731 |
| 22 | GRK7 | 1.39019236 |
| 23 | ILK | 1.36714470 |
| 24 | PAK3 | 1.33903552 |
| 25 | CDC42BPA | 1.24431585 |
| 26 | MARK1 | 1.22509350 |
| 27 | PRKD1 | 1.21687009 |
| 28 | CAMK2D | 1.19584320 |
| 29 | FLT3 | 1.12712849 |
| 30 | STK4 | 1.07319964 |
| 31 | MAP3K7 | 1.04164444 |
| 32 | ROCK1 | 1.03583978 |
| 33 | TRPM7 | 1.01802321 |
| 34 | MAPK12 | 0.96391414 |
| 35 | WNK4 | 0.95357644 |
| 36 | DAPK3 | 0.95011724 |
| 37 | MAPKAPK3 | 0.93884678 |
| 38 | MAP3K5 | 0.90029245 |
| 39 | MAP2K3 | 0.89649026 |
| 40 | MAP3K3 | 0.86356019 |
| 41 | PRKAA1 | 0.81786486 |
| 42 | INSRR | 0.81571652 |
| 43 | EEF2K | 0.81088921 |
| 44 | PRKAA2 | 0.80865131 |
| 45 | RIPK1 | 0.76751220 |
| 46 | PKN1 | 0.75631877 |
| 47 | CAMK4 | 0.71645712 |
| 48 | KDR | 0.70993022 |
| 49 | MAPK7 | 0.63078742 |
| 50 | CCNB1 | 0.60768639 |
| 51 | CAMK1 | 0.60390588 |
| 52 | PDGFRA | 0.59080955 |
| 53 | PTK2B | 0.58007275 |
| 54 | MAPK4 | 0.57923098 |
| 55 | RPS6KC1 | 0.56645606 |
| 56 | RPS6KL1 | 0.56645606 |
| 57 | ROCK2 | 0.55736445 |
| 58 | MOS | 0.55532680 |
| 59 | CAMK2A | 0.55470231 |
| 60 | STK38 | 0.54986921 |
| 61 | NME2 | 0.52338748 |
| 62 | DYRK1B | 0.50768375 |
| 63 | TGFBR2 | 0.50042066 |
| 64 | PRKACB | 0.49420097 |
| 65 | CAMK2B | 0.49249838 |
| 66 | WNK1 | 0.49020232 |
| 67 | RPS6KA6 | 0.47646179 |
| 68 | MAP2K1 | 0.47549109 |
| 69 | ERBB3 | 0.47130769 |
| 70 | MAP3K6 | 0.46695030 |
| 71 | KSR2 | 0.46626408 |
| 72 | NEK9 | 0.46623153 |
| 73 | EPHA3 | 0.46322601 |
| 74 | AKT2 | 0.43179087 |
| 75 | STK39 | 0.41012613 |
| 76 | PRKACA | 0.39094161 |
| 77 | PIK3CG | 0.38205594 |
| 78 | CAMK2G | 0.37158249 |
| 79 | PRKACG | 0.36655474 |
| 80 | NME1 | 0.36136637 |
| 81 | PRKCE | 0.34889318 |
| 82 | LIMK1 | 0.34786859 |
| 83 | MAP3K13 | 0.32499199 |
| 84 | RPS6KB2 | 0.27843031 |
| 85 | PTK6 | 0.27788434 |
| 86 | PRKD3 | 0.27097375 |
| 87 | PRKG2 | 0.26765305 |
| 88 | EPHB1 | 0.25500936 |
| 89 | PDPK1 | 0.25052763 |
| 90 | LATS1 | 0.24477422 |
| 91 | SIK1 | 0.23489434 |
| 92 | PRKG1 | 0.23412388 |
| 93 | RPS6KA1 | 0.23320989 |
| 94 | SGK2 | 0.22275184 |
| 95 | MAPK10 | 0.21982233 |
| 96 | EPHB2 | 0.21879193 |
| 97 | PDK1 | 0.21240959 |
| 98 | ICK | 0.20713671 |
| 99 | PRKCH | 0.20691235 |
| 100 | MARK3 | 0.18833699 |
| 101 | LRRK2 | 0.17946037 |
| 102 | MAP3K11 | 0.17452766 |
| 103 | MAP3K10 | 0.17419878 |
| 104 | MAPK11 | 0.17398954 |
| 105 | RAF1 | 0.16306854 |
| 106 | LATS2 | 0.16034228 |
| 107 | ARAF | 0.15069951 |
| 108 | MAP2K4 | 0.14541140 |
| 109 | JAK1 | 0.14250529 |
| 110 | MARK2 | 0.13775461 |
| 111 | ZAP70 | 0.13260559 |
| 112 | TBK1 | 0.12867838 |
| 113 | FER | 0.12788317 |
| 114 | NLK | 0.12187340 |
| 115 | SGK3 | 0.11826762 |
| 116 | STK11 | 0.11665053 |
| 117 | MAP3K1 | 0.11634564 |
| 118 | UHMK1 | 0.11490663 |
| 119 | MTOR | 0.10886400 |
| 120 | RET | 0.10817092 |
| 121 | FGFR4 | 0.10808375 |
| 122 | PRKCQ | 0.09978223 |
| 123 | MAPKAPK2 | 0.09792892 |
| 124 | RPS6KA3 | 0.09289344 |
| 125 | RPS6KB1 | 0.09205529 |
| 126 | SGK1 | 0.08891339 |
| 127 | MAP2K6 | 0.06864345 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 5.87830212 |
| 2 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 4.49375900 |
| 3 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 4.28244277 |
| 4 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 3.63728463 |
| 5 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 3.60785950 |
| 6 | Parkinsons disease_Homo sapiens_hsa05012 | 3.42912299 |
| 7 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.32153780 |
| 8 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 3.31920919 |
| 9 | Propanoate metabolism_Homo sapiens_hsa00640 | 3.27328454 |
| 10 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.96421103 |
| 11 | Carbon metabolism_Homo sapiens_hsa01200 | 2.62278954 |
| 12 | Alzheimers disease_Homo sapiens_hsa05010 | 2.46731356 |
| 13 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.38635906 |
| 14 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 2.29215291 |
| 15 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 2.26942684 |
| 16 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.19812405 |
| 17 | Huntingtons disease_Homo sapiens_hsa05016 | 2.16239407 |
| 18 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.91238427 |
| 19 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.80228538 |
| 20 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.64269481 |
| 21 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.52352419 |
| 22 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.47902440 |
| 23 | Viral myocarditis_Homo sapiens_hsa05416 | 1.47547382 |
| 24 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.40171337 |
| 25 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.37814405 |
| 26 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.24253524 |
| 27 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.18846668 |
| 28 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.15269860 |
| 29 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.13269988 |
| 30 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.04551608 |
| 31 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.00028304 |
| 32 | Insulin resistance_Homo sapiens_hsa04931 | 0.95752444 |
| 33 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.95693467 |
| 34 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.93710259 |
| 35 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.89306955 |
| 36 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.84438324 |
| 37 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.82816565 |
| 38 | Peroxisome_Homo sapiens_hsa04146 | 0.76602745 |
| 39 | Galactose metabolism_Homo sapiens_hsa00052 | 0.75256964 |
| 40 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.75031486 |
| 41 | Lysine degradation_Homo sapiens_hsa00310 | 0.72600873 |
| 42 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.72296093 |
| 43 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.71963505 |
| 44 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.66872119 |
| 45 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.62795501 |
| 46 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.62328354 |
| 47 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.61408623 |
| 48 | Focal adhesion_Homo sapiens_hsa04510 | 0.60443839 |
| 49 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.56087930 |
| 50 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.56040080 |
| 51 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.55989510 |
| 52 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.55164875 |
| 53 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.54817384 |
| 54 | Tight junction_Homo sapiens_hsa04530 | 0.51307786 |
| 55 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.50170562 |
| 56 | Long-term potentiation_Homo sapiens_hsa04720 | 0.48094031 |
| 57 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.47901083 |
| 58 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.44159359 |
| 59 | Salivary secretion_Homo sapiens_hsa04970 | 0.43733153 |
| 60 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.43043015 |
| 61 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.42388787 |
| 62 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.40380618 |
| 63 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.39788959 |
| 64 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.39568119 |
| 65 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.37411038 |
| 66 | Metabolic pathways_Homo sapiens_hsa01100 | 0.36234006 |
| 67 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.35155404 |
| 68 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.33019823 |
| 69 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.31300116 |
| 70 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.30489092 |
| 71 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.28611532 |
| 72 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.28049240 |
| 73 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.27327395 |
| 74 | Adherens junction_Homo sapiens_hsa04520 | 0.26617952 |
| 75 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.25540021 |
| 76 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.24193409 |
| 77 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.24109985 |
| 78 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.23357131 |
| 79 | Melanogenesis_Homo sapiens_hsa04916 | 0.21626250 |
| 80 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.21379573 |
| 81 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.18544588 |
| 82 | Amoebiasis_Homo sapiens_hsa05146 | 0.18450836 |
| 83 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.18434721 |
| 84 | Renin secretion_Homo sapiens_hsa04924 | 0.18421636 |
| 85 | Bile secretion_Homo sapiens_hsa04976 | 0.16113627 |
| 86 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.15256874 |
| 87 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.15043992 |
| 88 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.14870426 |
| 89 | GABAergic synapse_Homo sapiens_hsa04727 | 0.11216973 |
| 90 | Insulin secretion_Homo sapiens_hsa04911 | 0.11163818 |
| 91 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.11082155 |
| 92 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.09485505 |
| 93 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.09430706 |
| 94 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.09348481 |
| 95 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.08799258 |
| 96 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.08377314 |
| 97 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.08041008 |
| 98 | Circadian rhythm_Homo sapiens_hsa04710 | 0.07753316 |
| 99 | Sulfur relay system_Homo sapiens_hsa04122 | 0.07291679 |
| 100 | Endometrial cancer_Homo sapiens_hsa05213 | 0.07051076 |
| 101 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.06185519 |
| 102 | Long-term depression_Homo sapiens_hsa04730 | 0.05829229 |
| 103 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.03154385 |
| 104 | Platelet activation_Homo sapiens_hsa04611 | 0.03134071 |
| 105 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.02526528 |
| 106 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.02455343 |
| 107 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.02327469 |
| 108 | Circadian entrainment_Homo sapiens_hsa04713 | 0.00638839 |
| 109 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | -0.0863113 |
| 110 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | -0.0857782 |
| 111 | Gap junction_Homo sapiens_hsa04540 | -0.0834456 |
| 112 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | -0.0786277 |
| 113 | VEGF signaling pathway_Homo sapiens_hsa04370 | -0.0658198 |
| 114 | Toxoplasmosis_Homo sapiens_hsa05145 | -0.0621925 |
| 115 | Glutathione metabolism_Homo sapiens_hsa00480 | -0.0475977 |
| 116 | Small cell lung cancer_Homo sapiens_hsa05222 | -0.0462204 |
| 117 | FoxO signaling pathway_Homo sapiens_hsa04068 | -0.0376717 |
| 118 | mTOR signaling pathway_Homo sapiens_hsa04150 | -0.0280087 |
| 119 | ABC transporters_Homo sapiens_hsa02010 | -0.0071868 |
| 120 | Renal cell carcinoma_Homo sapiens_hsa05211 | -0.0004856 |

